Salarius Pharmaceuticals Inc. has announced a new listing involving the registered offering of up to $2,600,000 worth of common stock shares. These shares are listed with a par value of $0.0001 per share. The offering is conducted under the At the Market Offering Agreement with Ladenburg Thalmann & Co. Inc., following the filing of a prospectus supplement to an effective registration statement with the U.S. Securities and Exchange Commission.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Salarius Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001615219-25-000117), on August 26, 2025, and is solely responsible for the information contained therein.